Literature DB >> 15061748

Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease.

Paul G Shekelle1, Sally C Morton, Lara K Jungvig, Jay Udani, Myles Spar, Wenli Tu, Marika J Suttorp, Ian Coulter, Sydne J Newberry, Mary Hardy.   

Abstract

OBJECTIVE: To evaluate and synthesize the evidence on the effect of supplements of vitamin E on the prevention and treatment of cardiovascular disease.
DESIGN: Systematic review of placebo-controlled randomized controlled trials; meta-analysis where justified.
MEASUREMENTS AND MAIN RESULTS: Eighty-four eligible trials were identified. For the outcomes of all-cause mortality, cardiovascular mortality, fatal or nonfatal myocardial infarction, and blood lipids, neither supplements of vitamin E alone nor vitamin E given with other agents yielded a statistically significant beneficial or adverse pooled relative risk (for example, pooled relative risk of vitamin E alone = 0.96 [95% confidence interval (CI), 0.84 to 1.10]; 0.97 [95% CI, 0.80 to 1.90]; and 0.72 [95% CI, 0.51 to 1.02] for all-cause mortality, cardiovascular mortality, and nonfatal myocardial infarction, respectively.
CONCLUSIONS: There is good evidence that vitamin E supplementation does not beneficially or adversely affect cardiovascular outcomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15061748      PMCID: PMC1492195          DOI: 10.1111/j.1525-1497.2004.30090.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  48 in total

Review 1.  Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Cynthia D Morris; Susan Carson
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

Review 2.  Antioxidant nutrients and disease prevention: an overview.

Authors:  A T Diplock
Journal:  Am J Clin Nutr       Date:  1991-01       Impact factor: 7.045

3.  A controlled, double-blind study of dl-alpha-tocopheryl nicotinate (Juvela-Nicotinate) for treatment of symptoms in hypertension and cerebral arteriosclerosis.

Authors:  K Iino; K Abe; S Kariya; H Kimura; T Kusaba
Journal:  Jpn Heart J       Date:  1977-05

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Letter: Vitamin E in intermittent claudication.

Authors:  K Haeger
Journal:  Lancet       Date:  1974-06-29       Impact factor: 79.321

6.  The treatment of peripheral occlusive arterial disease with alpha-tocopherol as compared with vasodilator agents and antiprothrombin (dicumarol).

Authors:  K Haeger
Journal:  Vasc Dis       Date:  1968-12

7.  Quantitative evaluation of vitamin E in the treatment of angina pectoris.

Authors:  R E Gillilan; B Mondell; J R Warbasse
Journal:  Am Heart J       Date:  1977-04       Impact factor: 4.749

Review 8.  Antioxidants and heart disease: epidemiology and clinical evidence.

Authors:  C H Hennekens; J M Gaziano
Journal:  Clin Cardiol       Date:  1993-04       Impact factor: 2.882

9.  Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris.

Authors:  J M Rapola; J Virtamo; S Ripatti; J K Haukka; J K Huttunen; D Albanes; P R Taylor; O P Heinonen
Journal:  Heart       Date:  1998-05       Impact factor: 5.994

10.  Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.

Authors:  Deepak P Vivekananthan; Marc S Penn; Shelly K Sapp; Amy Hsu; Eric J Topol
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

View more
  24 in total

Review 1.  Focus on Pivotal Role of Dietary Intake (Diet and Supplement) and Blood Levels of Tocopherols and Tocotrienols in Obtaining Successful Aging.

Authors:  Mariangela Rondanelli; Milena Anna Faliva; Gabriella Peroni; Francesca Moncaglieri; Vittoria Infantino; Maurizio Naso; Simone Perna
Journal:  Int J Mol Sci       Date:  2015-09-25       Impact factor: 5.923

2.  Vitamin E might increase risk of death.

Authors:  Michael Lock; Andrew Loblaw
Journal:  Can Fam Physician       Date:  2005-06       Impact factor: 3.275

Review 3.  Drugs for cardiovascular disease prevention in women: implications of the AHA Guidelines--2007 Update.

Authors:  Nanette K Wenger
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Reporting of systematic reviews of micronutrients and health: a critical appraisal.

Authors:  Mei Chung; Ethan M Balk; Stanley Ip; Gowri Raman; Winifred W Yu; Thomas A Trikalinos; Alice H Lichtenstein; Elizabeth A Yetley; Joseph Lau
Journal:  Am J Clin Nutr       Date:  2009-02-25       Impact factor: 7.045

Review 5.  Good stress, bad stress--the delicate balance in the vasculature.

Authors:  Kirstin Wingler; Harald H H W Schmidt
Journal:  Dtsch Arztebl Int       Date:  2009-10-16       Impact factor: 5.594

Review 6.  Coronary heart disease prevention: nutrients, foods, and dietary patterns.

Authors:  Shilpa N Bhupathiraju; Katherine L Tucker
Journal:  Clin Chim Acta       Date:  2011-05-07       Impact factor: 3.786

Review 7.  Vitamin E in renal therapeutic regiments.

Authors:  Mohamed Alaa Thabet; James C M Chan
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

Review 8.  Secondary prevention of ischaemic cardiac events.

Authors:  Jane S Skinner; Angela Cooper
Journal:  BMJ Clin Evid       Date:  2011-08-30

9.  Adverse effects of vitamin E by induction of drug metabolism.

Authors:  Regina Brigelius-Flohé
Journal:  Genes Nutr       Date:  2007-10-16       Impact factor: 5.523

Review 10.  Primary prevention of CVD: diet and weight loss.

Authors:  Lee Hooper
Journal:  BMJ Clin Evid       Date:  2007-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.